GSK-2636771 Uses, Dosage, Side Effects and more
GSK2636771 has been used in trials studying the treatment of CANCER, LYMPHOMA, Solid Neoplasm, Recurrent Solid Neoplasm, and Advanced Malignant Neoplasm, among others.
| Trade Name | GSK-2636771 |
| Generic | GSK-2636771 |
| Type | |
| Formula | C22H22F3N3O3 |
| Weight | Average: 433.431 Monoisotopic: 433.161326069 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
